Drug Database
AM

ammonium lactate

✓ Approved

Bristol-Myers Squibb · Small Molecule · Small Molecule

What is ammonium lactate?

ammonium lactate is a small molecule developed by Bristol-Myers Squibb. It is approved for therapeutic indications via unknown.

Drug Profile

CompanyBristol-Myers Squibb
Drug ClassSmall Molecule
RouteUnknown
StatusApproved

Therapeutic Indications

ammonium lactate is developed for 3 unique indications across 3 therapeutic areas.

Therapeutic AreaConditionPhase
Congenital, familial and genetic disordersIchthyosis✓ Approved
Skin and subcutaneous tissue disordersPruritus✓ Approved
General disorders and administration site conditionsXerosis✓ Approved

Related Research Articles

PubMedFrontiers in physiology2026-09-19

Controlled breathing is associated with lower blood lactate than normobaric hypoxia despite comparable peripheral oxygen saturation during moderate-intensity exercise: an exploratory crossover study.

Fisher A J AJ, Hirsch Jessie J, Walker Kaela K, Rothstein Alexander A et al.

Blood lactate accumulation during exercise has traditionally been associated with reduced oxygen availability and an increased reliance on glycolytic metabolism. However, lactate production is influenced by multiple processes beyond oxygen availability. Previous pilot work demonstrated that a standardized controlled breathing intervention produced intermittent reductions in peripheral oxygen saturation comparable to intermittent hypoxic training, but its effects on blood lactate had not been investigated. This crossover study compared normobaric hypoxia (NH) and controlled breathing (CB). We hypothesized that both interventions would increase blood lactate accumulation relative to control. Fifteen healthy adults completed three laboratory visits using a within-subject crossover design. Participants performed an identical 30-minute functional exercise protocol during control (CON), NH (15% inspired oxygen), and CB. Blood lactate was measured at rest, after 10, 20, and 30 minutes of exercise, and after 10 minutes of recovery. Blood lactate AUC, maximum blood lactate, average HR, peripheral oxygen saturation (SpO2), and ratings of perceived exertion (RPE) were assessed. Data were analyzed using linear mixed-effects models with Tukey-adjusted pairwise comparisons. Contrary to hypothesis, NH and CB produced different metabolic responses despite reducing peripheral oxygen saturation. Blood lactate differed among conditions over time (condition × time interaction, p = 0.007), with CB demonstrating lower blood lactate than CON at 10, 20, 30 minutes, and recovery, and lower blood lactate than NH at 20 and 30 minutes. Maximum blood lactate (p = 0.002), blood lactate AUC (p < 0.001), and average HR (p < 0.001) were significantly lower during CB. NH produced greater reductions in peripheral oxygen saturation than CB, although both interventions reduced SpO2 relative to CON. RPE did not differ among conditions (p = 0.371). A standardized controlled breathing intervention was associated with lower blood lactate accumulation, cumulative lactate exposure, peak blood lactate concentration, and average HR despite significant reductions in peripheral oxygen saturation during moderate-intensity exercise. These exploratory findings suggest pulse oximetry-measured peripheral oxygen saturation may not fully predict metabolic responses to exercise. Because underlying mechanisms were not directly assessed, future mechanistic studies using direct measurements of skeletal muscle oxygenation, gas exchange, and metabolic regulation are warranted.

PubMedNaunyn-Schmiedeberg's archives of pharmacology2026-09-19

TRIM28 facilitates diffuse large B-cell lymphoma progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis.

Xin Liuyan L, Li An A, Xiao Wei W, Yu Jiaqi J et al.

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignancy in which metabolic adaptation contributes to aggressive behavior and treatment resistance. Although TRIM28 has been implicated in several cancers, its role in DLBCL remains unclear. Here, we investigated the function of TRIM28 in DLBCL progression and glycolytic reprogramming. TRIM28 expression was elevated in the TCGA DLBC cohort and in DLBCL cell lines compared with the normal B-cell line GM12878, and it was positively correlated with PKM2 expression in GEPIA. Gain- and loss-of-function assays showed that TRIM28 promoted cell proliferation and migration while suppressing apoptosis. Metabolic analyses further demonstrated that TRIM28 increased extracellular acidification, ATP production, lactate generation, and the expression of glycolysis-related genes, including PFKFB3, HK2, and PKM2. Mechanistically, bioinformatic analysis and dual-luciferase reporter assays identified PKM2 as a transcriptional target of E2F1, and TRIM28 upregulated E2F1 at both mRNA and protein levels, suggesting that TRIM28 acts upstream of the E2F1/PKM2 axis. Importantly, silencing either E2F1 or PKM2 markedly attenuated the effects of TRIM28 on DLBCL cell growth, migration, and glycolytic activity. In a xenograft model, TRIM28 overexpression accelerated tumor growth, whereas E2F1 or PKM2 knockdown significantly reversed these effects. Collectively, TRIM28 facilitates DLBCL progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis, highlighting a potential therapeutic target.

PubMedEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026-09-19

From signals to phenotype: multifactorial drivers of tumor-associated macrophage polarization in oral cavity squamous cell carcinoma: a narrative review.

Hamdan Ahmad Mohammad AM, El-Sehrawy Amr Ali Mohamed Abdelgawwad AAMA, Davlatova Aziza A, Tailor Navin Kumar NK et al.

This narrative review aimed to integrate oral cavity squamous cell carcinoma (OSCC)-specific evidence on the signals shaping the spatial and functional heterogeneity of tumor-associated macrophages (TAMs) and to evaluate their implications for tumor progression, treatment response, biomarker development, and therapeutic targeting. PubMed/MEDLINE, Scopus, and Web of Science were searched from database inception to July 15, 2026, for mechanistic, spatial, preclinical, translational, and clinical studies concerning TAM recruitment, polarization, tumor-macrophage crosstalk, biomarkers, and TAM-directed interventions in OSCC. Broader head and neck squamous cell carcinoma evidence was considered only when directly relevant OSCC-specific evidence was limited. The available evidence supports a continuum model of macrophage activation rather than a rigid M1/M2 classification. Hypoxia, lactate accumulation, cytokine and chemokine signaling, cancer-associated fibroblasts, extracellular-matrix remodeling, extracellular vesicles, and oral microbial cues converge to generate heterogeneous TAM states. These states can promote immune suppression, angiogenesis, epithelial-mesenchymal plasticity, invasion, metastatic niche formation, and resistance to immunotherapy or radiochemotherapy. CD163- and CD206-enriched macrophage populations are frequently associated with adverse clinicopathologic features, whereas treatment-related changes in macrophage composition may provide exploratory response-associated or pharmacodynamic information. Preclinical studies further indicate that disrupting recruitment, survival, metabolic, microbial, or vesicle-mediated feedback circuits, or reprogramming suppressive TAMs, can reduce tumor-promoting activity. TAMs should be evaluated as spatially organized, functionally diverse, and treatment-responsive populations. Clinically useful biomarkers and therapeutic approaches will require standardized, function-based characterization and prospective validation of rational combinations with immunotherapy and radiochemotherapy.

PubMedCell biochemistry and biophysics2026-09-19

Acetone Extract of Annona Muricata Linn Leaf Counteracts Hyperglycemia-Associated Metabolic Dysregulation by Modulating Oxidative Stress and Hepatic Carbohydrate Metabolism in Streptozotocin-Induced Diabetic Rats.

Omiyale Benjamin Olusola BO, Ekundayo Bidemi Emmanuel BE, Olusola Olutosin Samuel OS, Idowu Olajumoke Tolulope OT et al.

Annona muricata is widely recognized for its rich phenolic composition and potent antioxidant activity, suggesting therapeutic potential in diabetes management. This study investigated the mechanistic antidiabetic effects of acetone extract of A. muricata leaf on hepatic carbohydrate metabolism, oxidative stress, and hepatic function in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced in forty-two male Wistar rats by intraperitoneal injection of STZ (55 mg/kg). Diabetic animals (n = 7 per group) were treated with 25, 50, and 100 mg/kg of the extract (yield: 10.08% w/w) for 28 days, while metformin (200 mg/kg) served as the standard drug. Hepatic antioxidant enzyme activities, lipid peroxidation, serum albumin, lactate dehydrogenase (LDH), and histopathological alterations were evaluated to assess oxidative status and hepatic function, alongside the activities of key carbohydrate-metabolizing enzymes and mRNA expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) and glucose transporter 4 (GLUT4). Administration of the acetone extract significantly enhanced hepatic antioxidant defenses, as demonstrated by increased levels of glutathione and increased activities of antioxidant enzymes, accompanied by a marked reduction in lipid peroxidation. Additionally, the extract significantly restored serum albumin levels and reduced LDH activity, indicating improved hepatocellular integrity. Furthermore, the extract significantly impacted the activities of carbohydrate-metabolizing enzymes and restored the expression of PPAR-γ and GLUT4 toward physiological levels. These results suggest that the antidiabetic activity of A. muricata may be mediated by the attenuation of oxidative stress, preservation of hepatic function, and regulation of hepatic carbohydrate metabolism and glucose transporter signalling pathways, highlighting its potential as a promising phytotherapeutic agent for the management of diabetes.

PubMedActa obstetricia et gynecologica Scandinavica2026-09-19

Dual acellular subnormothermic machine perfusion for enhanced uterus preservation in a swine model.

Cabanel Lucile L, Oubari Haïzam H, Ellis Bradley W BW, Dion Ludivine L et al.

Machine perfusion has rapidly developed in the last decade and demonstrated improved preservation of conventional and marginal organs by reducing ischemia and hypoxia injuries. The aim of this study was to assess whether subnormothermic machine perfusion improves graft preservation compared with SCS in a porcine uterus model. Swine uteri were procured from circulatory-dead donors and allocated into two groups. In the experimental group, the organs were preserved with 4 h-dual subnormothermic machine perfusion (n = 4) while the control group (n = 4) underwent 4 h-static cold storage. After preservation, all uteri received ex vivo whole blood normothermic reperfusion (NMP) to simulate transplantation. Perfusate samples were analyzed from uterine arteries and veins every 30 min for gas and metabolic analysis, and weight variations were recorded continuously during perfusion. Following simulated transplantation, uterine contraction was assessed after oxytocin injection, and macrovascular perfusion was evaluated using contrast angiography. Several biopsies were procured from different parts of the uterus for histological and immunohistochemistry analysis. In the experimental group, the weight of the uteri and lactate difference between vein and artery decreased during subnormothermic machine perfusion. Weight gain was significantly higher in the control group (p = 0.03), which was consistent with interstitial edema observed on histological sections in this group. Uterine contraction evaluated through semi-quantitative scoring was higher in the experimental group (p = 0.02). In this porcine model, subnormothermic machine perfusion reduces edema and preserves contractility more effectively than static cold storage. We demonstrate its particular interest in recovering organs procured from deceased donors. In addition, subnormothermic machine perfusion may enable other applications, including graft assessment, treatment and tolerance induction.

PubMedNational science review2026-09-18

Hydrogen bonding: a double-edged sword in aqueous ammonium-ion batteries.

Zheng Runtian R, Shu Jie J, Li Yu Y, Su Bao-Lian BL

Hydrogen bonding plays a double-edged role in ammonium-ion batteries, facilitating ion transport and flexible storage while inducing instability. Rational regulation of these interactions is crucial for achieving high-performance.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about ammonium lactate